Abstract
Objective
To describe the impact of population admixture on the distribution of the GNB3 825C>T polymorphism in the heterogeneous Brazilian population.
Methods
Individual DNA from 236 healthy Brazilians, self-identified as White, Intermediate and Black, was genotyped for a set of insertion/deletion polymorphisms that have been previously validated as ancestry informative markers (AIMs). The GNB3 825C>T polymorphism was detected by PCR-RFLP. Non-linear logistic regression modeling was applied to describe the association between the GNB3 825C>T polymorphisms and the African component of ancestry (ACA) estimated by the AIMs.
Results
The GNB3 825C>T allele and genotype distribution differed significantly across the three self-reported groups (P < 0.0001, χ2 test), with a trend for increasing frequency of both the GNB3 825T allele and the TT genotype from White to Intermediate to Black individuals (P < 0.0001, χ2 test for trend in proportions). Non-linear logistic regression showed that the odds of having the GNB3 825C>T allele increase monotonically (P < 0.0001, Wald statistics) with increasing ACA throughout the ACA range (0.136–0.897) observed in the overall population sample, irrespective of “racial/color” self-identification.
Conclusion
The present data on the GNB3 825C>T polymorphism support the notion that interethnic admixture, which is a source of spurious genotype–phenotype associations in pharmacogenetic/-genomic studies, must be dealt with as a continuous variable, rather than proportioned in arbitrary sub-categories for the convenience of data quantification and analysis.
Similar content being viewed by others
References
Zill P, Baghai TC, Zwanager P, Schüle C, Minov C, Reidel M, Neumeier K, Rupprecht R, Brondy B (2000) Evidence for an association between a G-protein b3 gene variant with depression and response to antidepressant treatment. Neuroreport 11(9):1893–1897
Nürnberger J, Dammer S, Mitchell A, Siffert W, Wenzel RR, Gössl M, Philipp T, Michel MC, Schäfers RF (2003) Effect of the C825T polymorphism of the G protein b3 subunit on the systolic blood pressure-lowering effect of clonidine in young, healthy male subjects. Clin Pharmacol Ther 74(1):53–60
Hauner H, Meier M, Jöckel KH, Frey UH, Siffert W (2003) Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein b3 subunit gene (GNB3) C825T polymorphism. Pharmacogenetics 13(8):453–459
Mitchell A, Bührmann S, Seifert A, Nürnberger J, Wenzel RR, Siffert W, Philipp T, Schäfers RF (2003) Venous response to nitroglycerin is enhanced in young, healthy carriers of the 825 T allele of the G protein b3 subunit gene (GNB3). Clin Pharmacol Ther 74(5):499–504
Lee HJ, Cha JH, Ham BJ, Han CS, Kim YK, Lee SH, Ryu SH, Kang RH, Choi MJ, Lee MS (2004) Association between a G-protein b3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders. Pharmacogenomics J 4(1):29–33
Muller DJ, De Luca V, Sicard T, King N, Hwang R, Volavka J, Czobor P, Sheitman BB, Lindenmayer JP, Citrome L, McEvoy JP, Lieberman JA, Meltzer HY, Kennedy JL (2005) Suggestive association between the C825T polymorphism of the G-protein b3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia. Eur Neuropsychopharmacol 15(5):525–531
Schurks M, Kurth T, Stude P, Rimmbach C, de Jesus J, Jonjic M, Diener HC, Rosskopf D (2007) G protein beta3 polymorphism and triptan response in cluster headache. Clin Pharmacol Ther 82(4):396–401
Rosskopf D, Manthey I, Siffert W (2002) Identification and ethnic distribution of major haplotypes in the gene GNB3 encoding the G-protein beta3 subunit. Pharmacogenetics 12(3):209–220
Siffert W, Forster P, Jockel KH, Mvere DA, Brinkmann B, Naber C, Crookes R, Du P, Heyns A, Epplen JT, Fridey J, Freedman BI, Muller N, Stolke D, Sharma AM, Al Moutaery K, Grosse-Wilde H, Buerbaum B, Ehrlich T, Ahmad HR, Horsthemke B, Du Toit ED, Tiilikainen A, Ge J, Wang Y, Rosskopf D (1999) Worldwide ethnic distribution of the G protein beta3 subunit 825 T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J Am Soc Nephrol 10(9):1921–1930
Salzano FM, Bortolini MC (2002) The evolution and genetics of Latin American populations. Cambridge University Press, Cambridge, UK
Suarez-Kurtz G, Vargens DG, Struchiner CJ, Bastos-Rodrigues L, Pena SDJ (2007) Self-reported skin color, genomic ancestry and the distribution of GST polymorphisms. Pharmacogenetics 17(9):765–771
Suarez-Kurtz G, Perini JA, Bastos-Rodrigues L, Pena SDJ, Struchiner CJ (2007) Impact of population admixture on the distribution of the CYP3A5*3 polymorphism. Pharmacogenomics 8(10):1299–1306
http://www.ibge.gov.br/home/estatistica/populacao/censo2000/. Cited 30 August 2007
Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, Sharma AM, Ritz E, Wichmann HE, Jakobs KH, Horsthemke B (1998) Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 18(1):45–48
Bastos-Rodrigues L, Pimenta JR, Pena SDJ (2006) The genetic structure of human populations studied through short insertion-deletion polymorphisms. Ann Hum Genet 70(5):658–665
Pritchard JK, Stephens M, Donnelly P (2000) Inference of population structure using multilocus genotype data. Genetics 155(2):945–959
http://pritch.bsd.uchicago.edu/software.html. Cited 5 August 2007
Harrell FE (ed) (2001) Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. Springer, Berlin Heidelberg New York
R Development Core Team (2005) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
Hothorn T, Hornik K, van de Wiel MA, Zeileis A (2006) A lego system for conditional inference. Am Stat 60:257–263
Danoviz ME, Pereira AC, Mill JG, Krieger JE (2006) Hypertension, obesity and GNB 3 gene variants. Clin Exp Pharmacol Physiol 33(3):248–252
Parra FC, Amado RC, Lambertucci JR, Rocha J, Antunes CM, Pena SDJ (2003) Color and genomic ancestry in Brazilians. Proc Natl Acad Sci USA 100(1):177–182
Suarez-Kurtz G, Pena SDJ (2006) Pharmacogenomics in the Americas: impact of genetic admixture. Curr Drug Targets 7(12):1649–1658
Suarez-Kurtz G, Pena SDJ (2007) In: Suarez-Kurtz G (ed) Pharmacogenomics in Admixed Populations, Landes Bioscience, Austin, USA, pp.75–98. Available at: http://www.eurekah.com/chapter/3157. Cited 30 August, 2007
Goldstein DB, Hirschhorn JN (2004) In genetic control of disease, does race matter? Nat Genet 36(12):1243–1244
Acknowledgments
This work was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Swiss Bridge Foundation. The authors declare that the experiments reported in this study comply with the current laws of Brazil.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vargens, D.D., Almendra, L., Struchiner, C.J. et al. Distribution of the GNB3 825C>T polymorphism among Brazilians: impact of population structure. Eur J Clin Pharmacol 64, 253–256 (2008). https://doi.org/10.1007/s00228-007-0413-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-007-0413-2